GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSRNOG00000019222 | transcription factor Dp-1 |
Wt1
|
ENSRNOG00000013074 | Wilms tumor 1 |
Egr2
|
ENSRNOG00000000640 | early growth response 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfdp1 | rn6_v1_chr16_+_81089292_81089308 | 0.67 | 1.4e-43 | Click! |
Egr2 | rn6_v1_chr20_-_22459025_22459025 | 0.36 | 5.8e-11 | Click! |
Wt1 | rn6_v1_chr3_+_95133713_95133713 | 0.17 | 2.0e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_86512797 | 118.15 |
ENSRNOT00000051680
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr6_+_44009872 | 99.64 |
ENSRNOT00000082657
|
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr14_+_87312203 | 88.94 |
ENSRNOT00000088032
|
Adcy1
|
adenylate cyclase 1 |
chr8_+_118333706 | 87.64 |
ENSRNOT00000028278
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr1_-_72727112 | 86.16 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr7_-_116607408 | 83.07 |
ENSRNOT00000076009
ENSRNOT00000056554 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr17_-_78962476 | 77.41 |
ENSRNOT00000030228
|
Nmt2
|
N-myristoyltransferase 2 |
chr19_+_52086325 | 75.91 |
ENSRNOT00000020341
|
Necab2
|
N-terminal EF-hand calcium binding protein 2 |
chr10_-_56444847 | 73.71 |
ENSRNOT00000056872
ENSRNOT00000092662 |
Nlgn2
|
neuroligin 2 |
chr10_+_13854339 | 73.44 |
ENSRNOT00000004486
ENSRNOT00000043951 |
Caskin1
|
CASK interacting protein 1 |
chr7_+_128500011 | 72.33 |
ENSRNOT00000074625
|
Fam19a5
|
family with sequence similarity 19 member A5, C-C motif chemokine like |
chr3_-_10602672 | 71.91 |
ENSRNOT00000011648
|
Ncs1
|
neuronal calcium sensor 1 |
chr3_-_80842916 | 69.61 |
ENSRNOT00000033978
|
Mdk
|
midkine |
chr3_-_11885311 | 68.97 |
ENSRNOT00000021189
ENSRNOT00000021178 |
Stxbp1
|
syntaxin binding protein 1 |
chr5_+_64326733 | 68.02 |
ENSRNOT00000065775
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr1_-_101360971 | 66.56 |
ENSRNOT00000028164
|
Lin7b
|
lin-7 homolog B, crumbs cell polarity complex component |
chr7_-_59514939 | 65.47 |
ENSRNOT00000085579
|
Kcnmb4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
chr6_+_132246602 | 62.21 |
ENSRNOT00000009896
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr9_+_38297322 | 61.18 |
ENSRNOT00000078157
ENSRNOT00000088824 |
Bend6
|
BEN domain containing 6 |
chr1_-_143751789 | 61.09 |
ENSRNOT00000026754
|
Hdgfrp3
|
hepatoma-derived growth factor, related protein 3 |
chr2_-_147959567 | 60.11 |
ENSRNOT00000063986
|
LOC100909840
|
profilin-2-like |
chr1_+_78800754 | 59.39 |
ENSRNOT00000084601
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr3_+_6773813 | 57.84 |
ENSRNOT00000065953
ENSRNOT00000013443 |
Olfm1
|
olfactomedin 1 |
chr7_+_70364813 | 57.48 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr10_+_77755216 | 57.46 |
ENSRNOT00000087765
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr19_-_11669578 | 56.96 |
ENSRNOT00000026373
|
Gnao1
|
G protein subunit alpha o1 |
chr2_+_207923775 | 55.94 |
ENSRNOT00000019997
ENSRNOT00000051835 |
Kcnd3
|
potassium voltage-gated channel subfamily D member 3 |
chr19_-_57192095 | 55.74 |
ENSRNOT00000058080
|
Pgbd5
|
piggyBac transposable element derived 5 |
chr3_-_92290919 | 55.57 |
ENSRNOT00000007077
|
Fjx1
|
four jointed box 1 |
chr16_-_5795825 | 55.12 |
ENSRNOT00000048043
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
chr10_+_15088935 | 54.63 |
ENSRNOT00000030273
|
Gng13
|
G protein subunit gamma 13 |
chr7_-_116607674 | 54.27 |
ENSRNOT00000076014
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr11_-_87017115 | 53.49 |
ENSRNOT00000051037
|
Rtn4r
|
reticulon 4 receptor |
chr15_-_48670257 | 53.06 |
ENSRNOT00000071464
|
Fzd3
|
frizzled class receptor 3 |
chr19_-_9801942 | 52.92 |
ENSRNOT00000051414
ENSRNOT00000017494 |
Ndrg4
|
NDRG family member 4 |
chr2_-_229718659 | 52.75 |
ENSRNOT00000012676
|
Ugt8
|
UDP glycosyltransferase 8 |
chr13_+_101181994 | 52.45 |
ENSRNOT00000052407
|
Susd4
|
sushi domain containing 4 |
chr10_+_93811505 | 51.62 |
ENSRNOT00000081937
|
Tanc2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr5_+_103479767 | 51.28 |
ENSRNOT00000008999
|
Sh3gl2
|
SH3 domain-containing GRB2-like 2 |
chr10_-_82197848 | 51.15 |
ENSRNOT00000081307
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G |
chr14_-_82048251 | 51.09 |
ENSRNOT00000074734
|
Nat8l
|
N-acetyltransferase 8-like |
chr10_-_83332851 | 50.71 |
ENSRNOT00000007133
|
Nxph3
|
neurexophilin 3 |
chr6_-_92760018 | 50.46 |
ENSRNOT00000009560
|
Trim9
|
tripartite motif-containing 9 |
chr19_-_11326139 | 50.24 |
ENSRNOT00000025669
|
Mt3
|
metallothionein 3 |
chr7_-_121058029 | 50.19 |
ENSRNOT00000068033
|
Cbx6
|
chromobox 6 |
chr6_-_137733026 | 50.18 |
ENSRNOT00000019213
|
Jag2
|
jagged 2 |
chr5_-_58019836 | 49.18 |
ENSRNOT00000066977
|
Enho
|
energy homeostasis associated |
chr2_-_148050423 | 48.96 |
ENSRNOT00000064506
ENSRNOT00000023469 |
LOC100909840
|
profilin-2-like |
chr12_+_24651314 | 48.67 |
ENSRNOT00000077016
ENSRNOT00000071569 |
Vps37d
|
VPS37D, ESCRT-I subunit |
chr7_+_140315368 | 48.45 |
ENSRNOT00000081206
|
Cacnb3
|
calcium voltage-gated channel auxiliary subunit beta 3 |
chr9_-_28973246 | 48.24 |
ENSRNOT00000091865
ENSRNOT00000015453 |
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr1_-_146556171 | 48.13 |
ENSRNOT00000017636
|
Arnt2
|
aryl hydrocarbon receptor nuclear translocator 2 |
chr20_+_12429315 | 47.68 |
ENSRNOT00000001675
|
Pcbp3
|
poly(rC) binding protein 3 |
chr20_+_5535432 | 47.54 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr10_+_86303727 | 47.43 |
ENSRNOT00000037752
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr9_+_99998275 | 47.34 |
ENSRNOT00000074395
|
Gpc1
|
glypican 1 |
chr11_+_34598492 | 46.86 |
ENSRNOT00000065600
|
Ttc3
|
tetratricopeptide repeat domain 3 |
chr5_+_166533181 | 46.61 |
ENSRNOT00000045063
|
Clstn1
|
calsyntenin 1 |
chr7_-_136853957 | 46.59 |
ENSRNOT00000008985
|
Nell2
|
neural EGFL like 2 |
chr12_-_44174583 | 46.46 |
ENSRNOT00000001490
|
Tesc
|
tescalcin |
chr10_+_86657285 | 46.34 |
ENSRNOT00000087346
|
Thra
|
thyroid hormone receptor alpha |
chr1_+_211423022 | 46.03 |
ENSRNOT00000029587
|
Dpysl4
|
dihydropyrimidinase-like 4 |
chr10_+_67862054 | 45.01 |
ENSRNOT00000031746
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1 |
chr1_+_226435979 | 44.57 |
ENSRNOT00000048704
ENSRNOT00000036232 ENSRNOT00000035576 ENSRNOT00000036180 ENSRNOT00000036168 ENSRNOT00000047964 ENSRNOT00000036283 ENSRNOT00000007429 |
Syt7
|
synaptotagmin 7 |
chrX_-_106558366 | 44.56 |
ENSRNOT00000042126
|
Bex2
|
brain expressed X-linked 2 |
chr4_-_71713063 | 44.39 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr12_+_17416327 | 44.29 |
ENSRNOT00000089590
ENSRNOT00000092186 |
Adap1
|
ArfGAP with dual PH domains 1 |
chr14_-_78902063 | 43.72 |
ENSRNOT00000088469
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr10_-_14788617 | 43.70 |
ENSRNOT00000043626
|
Cacna1h
|
calcium voltage-gated channel subunit alpha1 H |
chr6_+_43001948 | 42.90 |
ENSRNOT00000007374
|
Hpcal1
|
hippocalcin-like 1 |
chr3_+_113818872 | 42.21 |
ENSRNOT00000044158
|
Casc4
|
cancer susceptibility candidate 4 |
chr1_+_84470829 | 41.96 |
ENSRNOT00000025472
|
Ttc9b
|
tetratricopeptide repeat domain 9B |
chr6_-_51356383 | 41.66 |
ENSRNOT00000012415
|
Prkar2b
|
protein kinase cAMP-dependent type 2 regulatory subunit beta |
chr10_-_56167426 | 41.64 |
ENSRNOT00000013955
|
Efnb3
|
ephrin B3 |
chr7_+_73588163 | 41.47 |
ENSRNOT00000015707
|
Kcns2
|
potassium voltage-gated channel, modifier subfamily S, member 2 |
chr6_+_64297888 | 41.42 |
ENSRNOT00000050222
ENSRNOT00000083088 ENSRNOT00000093147 |
Nrcam
|
neuronal cell adhesion molecule |
chr8_+_119566509 | 41.11 |
ENSRNOT00000028633
|
Trank1
|
tetratricopeptide repeat and ankyrin repeat containing 1 |
chr14_-_86297623 | 40.85 |
ENSRNOT00000067162
ENSRNOT00000081607 ENSRNOT00000085265 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta |
chr1_+_84067938 | 40.61 |
ENSRNOT00000057213
|
Numbl
|
NUMB-like, endocytic adaptor protein |
chrX_-_118615798 | 40.55 |
ENSRNOT00000045463
|
Lrch2
|
leucine rich repeats and calponin homology domain containing 2 |
chr2_-_77632628 | 40.12 |
ENSRNOT00000073915
|
Basp1
|
brain abundant, membrane attached signal protein 1 |
chr1_+_213870502 | 39.93 |
ENSRNOT00000086483
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr4_+_7355574 | 39.55 |
ENSRNOT00000013800
|
Kcnh2
|
potassium voltage-gated channel subfamily H member 2 |
chr7_-_50638798 | 38.83 |
ENSRNOT00000048880
|
Syt1
|
synaptotagmin 1 |
chr1_+_87248489 | 38.60 |
ENSRNOT00000028091
|
Dpf1
|
double PHD fingers 1 |
chr1_-_198454914 | 38.45 |
ENSRNOT00000049044
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr10_+_55675575 | 38.36 |
ENSRNOT00000057295
|
Vamp2
|
vesicle-associated membrane protein 2 |
chr13_-_52197205 | 38.21 |
ENSRNOT00000009712
|
Shisa4
|
shisa family member 4 |
chr14_-_83062302 | 38.09 |
ENSRNOT00000086769
ENSRNOT00000085735 |
Ywhah
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chr5_+_43603043 | 37.89 |
ENSRNOT00000009899
|
Epha7
|
Eph receptor A7 |
chr14_-_85191557 | 37.72 |
ENSRNOT00000011604
|
Nefh
|
neurofilament heavy |
chr3_+_137618898 | 37.48 |
ENSRNOT00000007249
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr6_-_98157087 | 37.24 |
ENSRNOT00000013275
|
Kcnh5
|
potassium voltage-gated channel subfamily H member 5 |
chr1_-_89483988 | 36.85 |
ENSRNOT00000028603
|
Fxyd7
|
FXYD domain-containing ion transport regulator 7 |
chr5_-_62621737 | 36.74 |
ENSRNOT00000011573
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2 |
chr8_+_44136496 | 36.69 |
ENSRNOT00000087022
|
Scn3b
|
sodium voltage-gated channel beta subunit 3 |
chr17_+_9679628 | 36.65 |
ENSRNOT00000019569
ENSRNOT00000019393 |
Dbn1
|
drebrin 1 |
chr10_-_82197520 | 36.39 |
ENSRNOT00000092024
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G |
chr1_+_173607101 | 36.33 |
ENSRNOT00000074636
|
Tub
|
tubby bipartite transcription factor |
chrX_+_39711201 | 36.26 |
ENSRNOT00000080512
ENSRNOT00000009802 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr14_-_36554580 | 36.24 |
ENSRNOT00000002869
|
Rasl11b
|
RAS-like family 11 member B |
chr9_+_117538346 | 36.20 |
ENSRNOT00000022849
|
Epb41l3
|
erythrocyte membrane protein band 4.1-like 3 |
chr10_-_74679858 | 36.17 |
ENSRNOT00000003859
|
Ppm1e
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr5_-_75676584 | 36.16 |
ENSRNOT00000044348
|
Lpar1
|
lysophosphatidic acid receptor 1 |
chr3_-_163935617 | 36.11 |
ENSRNOT00000074023
|
Kcnb1
|
potassium voltage-gated channel subfamily B member 1 |
chr1_+_72860218 | 36.05 |
ENSRNOT00000024547
|
Syt5
|
synaptotagmin 5 |
chr7_+_78092037 | 36.05 |
ENSRNOT00000050753
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr3_+_152552822 | 35.89 |
ENSRNOT00000089719
|
Epb41l1
|
erythrocyte membrane protein band 4.1-like 1 |
chr14_+_2194933 | 35.67 |
ENSRNOT00000061720
|
Cplx1
|
complexin 1 |
chr8_-_94564525 | 35.64 |
ENSRNOT00000084437
|
Snap91
|
synaptosomal-associated protein 91 |
chr5_-_155204456 | 35.57 |
ENSRNOT00000089574
|
Ephb2
|
Eph receptor B2 |
chr4_+_25825567 | 35.39 |
ENSRNOT00000009417
|
Cdk14
|
cyclin-dependent kinase 14 |
chr6_-_103470427 | 35.31 |
ENSRNOT00000091560
ENSRNOT00000088795 ENSRNOT00000079824 |
Actn1
|
actinin, alpha 1 |
chrX_+_17540458 | 35.24 |
ENSRNOT00000045710
|
Nudt11
|
nudix hydrolase 11 |
chr8_+_44847157 | 35.22 |
ENSRNOT00000080288
|
Clmp
|
CXADR-like membrane protein |
chr13_-_102942863 | 35.18 |
ENSRNOT00000003198
|
Mark1
|
microtubule affinity regulating kinase 1 |
chr4_+_13405136 | 35.08 |
ENSRNOT00000091004
|
Gnai1
|
G protein subunit alpha i1 |
chr2_+_85377318 | 35.04 |
ENSRNOT00000016506
ENSRNOT00000085094 |
Sema5a
|
semaphorin 5A |
chr3_-_129357348 | 34.99 |
ENSRNOT00000084829
ENSRNOT00000007410 |
Pak7
|
p21 (RAC1) activated kinase 7 |
chr10_+_93811350 | 34.98 |
ENSRNOT00000077280
|
Tanc2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr2_+_225310624 | 34.92 |
ENSRNOT00000015836
|
F3
|
coagulation factor III, tissue factor |
chr3_-_176644951 | 34.92 |
ENSRNOT00000049961
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2 |
chr2_+_244058186 | 34.87 |
ENSRNOT00000021381
|
Tspan5
|
tetraspanin 5 |
chr4_-_123040609 | 34.73 |
ENSRNOT00000070832
|
Wnt7a
|
wingless-type MMTV integration site family, member 7A |
chr2_-_257864385 | 34.67 |
ENSRNOT00000072048
|
Ak5
|
adenylate kinase 5 |
chr7_-_70552897 | 34.64 |
ENSRNOT00000080594
|
Kif5a
|
kinesin family member 5A |
chr1_-_81946714 | 34.41 |
ENSRNOT00000027578
|
Grik5
|
glutamate ionotropic receptor kainate type subunit 5 |
chr1_-_42587666 | 34.24 |
ENSRNOT00000083225
ENSRNOT00000025355 |
Rgs17
|
regulator of G-protein signaling 17 |
chr15_+_52220578 | 34.18 |
ENSRNOT00000015104
|
Lgi3
|
leucine-rich repeat LGI family, member 3 |
chr5_+_148193710 | 34.14 |
ENSRNOT00000088568
|
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr3_-_147865393 | 34.09 |
ENSRNOT00000009852
|
Sox12
|
SRY box 12 |
chr4_+_147037179 | 34.07 |
ENSRNOT00000011292
|
Syn2
|
synapsin II |
chr8_-_110813000 | 33.95 |
ENSRNOT00000010634
|
Ephb1
|
Eph receptor B1 |
chr7_-_107009330 | 33.81 |
ENSRNOT00000074573
|
Kcnq3
|
potassium voltage-gated channel subfamily Q member 3 |
chr1_+_165237847 | 33.79 |
ENSRNOT00000022963
|
Pgm2l1
|
phosphoglucomutase 2-like 1 |
chr6_+_110624856 | 33.64 |
ENSRNOT00000014017
|
Vash1
|
vasohibin 1 |
chr4_-_64831233 | 33.62 |
ENSRNOT00000079285
|
Dgki
|
diacylglycerol kinase, iota |
chr15_+_38341089 | 33.42 |
ENSRNOT00000015367
|
Fgf9
|
fibroblast growth factor 9 |
chr3_-_11382004 | 33.35 |
ENSRNOT00000047921
ENSRNOT00000064039 |
Dnm1
|
dynamin 1 |
chr3_+_3325770 | 33.34 |
ENSRNOT00000023542
|
Kcnt1
|
potassium sodium-activated channel subfamily T member 1 |
chr7_-_105592804 | 33.33 |
ENSRNOT00000006789
|
Adcy8
|
adenylate cyclase 8 |
chrX_+_14358224 | 33.33 |
ENSRNOT00000005042
|
Lancl3
|
LanC like 3 |
chr18_+_83471342 | 33.31 |
ENSRNOT00000019384
|
Neto1
|
neuropilin and tolloid like 1 |
chrX_-_123600890 | 33.28 |
ENSRNOT00000067942
|
Sept6
|
septin 6 |
chr10_+_62674561 | 33.25 |
ENSRNOT00000019946
ENSRNOT00000056110 |
Ankrd13b
|
ankyrin repeat domain 13B |
chr4_+_49941304 | 33.00 |
ENSRNOT00000008719
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1 |
chr10_+_91710495 | 32.95 |
ENSRNOT00000033276
|
Rprml
|
reprimo-like |
chrX_+_1321315 | 32.94 |
ENSRNOT00000014250
|
Syn1
|
synapsin I |
chr5_-_157535664 | 32.87 |
ENSRNOT00000072299
|
Nbl1
|
neuroblastoma 1, DAN family BMP antagonist |
chr4_-_83137527 | 32.72 |
ENSRNOT00000039580
|
Jazf1
|
JAZF zinc finger 1 |
chr6_-_102196138 | 32.64 |
ENSRNOT00000014132
|
Tmem229b
|
transmembrane protein 229B |
chr1_-_188713270 | 32.61 |
ENSRNOT00000082192
ENSRNOT00000065892 |
Gprc5b
|
G protein-coupled receptor, class C, group 5, member B |
chr18_-_57031459 | 32.45 |
ENSRNOT00000026583
|
Pcyox1l
|
prenylcysteine oxidase 1 like |
chr11_+_31428358 | 32.43 |
ENSRNOT00000002827
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr15_-_61564695 | 32.42 |
ENSRNOT00000068216
|
Rgcc
|
regulator of cell cycle |
chr8_+_111600532 | 32.36 |
ENSRNOT00000081952
|
Rab6b
|
RAB6B, member RAS oncogene family |
chrX_-_38196060 | 32.34 |
ENSRNOT00000006741
ENSRNOT00000006438 |
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1 |
chr1_+_263186235 | 32.28 |
ENSRNOT00000021876
|
Cnnm1
|
cyclin and CBS domain divalent metal cation transport mediator 1 |
chr1_-_81881549 | 32.15 |
ENSRNOT00000027497
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3 |
chr19_-_40925660 | 32.10 |
ENSRNOT00000023645
|
Mtss1l
|
MTSS1L, I-BAR domain containing |
chr8_-_61290240 | 32.01 |
ENSRNOT00000023084
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr18_-_63357194 | 31.97 |
ENSRNOT00000089408
ENSRNOT00000066103 |
Spire1
|
spire-type actin nucleation factor 1 |
chr19_-_58399816 | 31.86 |
ENSRNOT00000026843
|
Sipa1l2
|
signal-induced proliferation-associated 1 like 2 |
chrX_-_104493714 | 31.70 |
ENSRNOT00000064458
ENSRNOT00000080386 |
Pcdh19
|
protocadherin 19 |
chr18_-_86878142 | 31.67 |
ENSRNOT00000058139
|
Dok6
|
docking protein 6 |
chr11_+_75905443 | 31.63 |
ENSRNOT00000002650
|
Fgf12
|
fibroblast growth factor 12 |
chr3_+_161433410 | 31.56 |
ENSRNOT00000024657
|
Slc12a5
|
solute carrier family 12 member 5 |
chr3_+_2462466 | 31.41 |
ENSRNOT00000014087
|
Rnf208
|
ring finger protein 208 |
chr3_-_160301552 | 31.37 |
ENSRNOT00000014498
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr7_+_12652415 | 30.92 |
ENSRNOT00000031315
|
Plppr3
|
phospholipid phosphatase related 3 |
chrX_+_157150655 | 30.67 |
ENSRNOT00000090795
|
Pnck
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr5_+_169452493 | 30.66 |
ENSRNOT00000014444
|
Gpr153
|
G protein-coupled receptor 153 |
chr7_-_11353713 | 30.54 |
ENSRNOT00000061132
|
Zfr2
|
zinc finger RNA binding protein 2 |
chr1_+_241594565 | 30.52 |
ENSRNOT00000020123
|
Apba1
|
amyloid beta precursor protein binding family A member 1 |
chr18_+_63203063 | 30.48 |
ENSRNOT00000024144
|
Prelid3a
|
PRELI domain containing 3A |
chr2_-_5579894 | 30.47 |
ENSRNOT00000020044
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1 |
chr15_-_58711872 | 30.46 |
ENSRNOT00000058204
|
Serp2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr5_+_139783951 | 30.39 |
ENSRNOT00000081333
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr1_+_29225707 | 30.35 |
ENSRNOT00000018849
|
Ncoa7
|
nuclear receptor coactivator 7 |
chr20_+_19318250 | 30.29 |
ENSRNOT00000000299
|
Phyhipl
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
chr8_+_128972311 | 30.20 |
ENSRNOT00000025460
|
Myrip
|
myosin VIIA and Rab interacting protein |
chrX_+_156963870 | 30.19 |
ENSRNOT00000077109
|
Pdzd4
|
PDZ domain containing 4 |
chr5_+_138154673 | 30.19 |
ENSRNOT00000064452
|
Slc2a1
|
solute carrier family 2 member 1 |
chr4_+_132137793 | 30.12 |
ENSRNOT00000014455
|
Gpr27
|
G protein-coupled receptor 27 |
chr12_+_2534212 | 30.08 |
ENSRNOT00000001399
|
Ctxn1
|
cortexin 1 |
chr20_+_44436403 | 29.99 |
ENSRNOT00000000733
ENSRNOT00000076859 |
Fyn
|
FYN proto-oncogene, Src family tyrosine kinase |
chr6_-_132972511 | 29.78 |
ENSRNOT00000082216
|
Begain
|
brain-enriched guanylate kinase-associated |
chr7_-_136853154 | 29.67 |
ENSRNOT00000087376
|
Nell2
|
neural EGFL like 2 |
chr8_-_57255263 | 29.65 |
ENSRNOT00000028972
|
LOC100125362
|
hypothetical protein LOC100125362 |
chr7_+_12433933 | 29.60 |
ENSRNOT00000060690
|
Cbarp
|
CACN beta subunit associated regulatory protein |
chr4_+_146106386 | 29.56 |
ENSRNOT00000008342
|
Slc6a11
|
solute carrier family 6 member 11 |
chr5_+_156876706 | 29.55 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr12_-_46920952 | 29.46 |
ENSRNOT00000001532
|
Msi1
|
musashi RNA-binding protein 1 |
chr7_+_141355994 | 29.46 |
ENSRNOT00000081195
|
Smarcd1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
chr14_+_77380262 | 29.40 |
ENSRNOT00000008030
|
Nsg1
|
neuron specific gene family member 1 |
chr5_+_29538380 | 29.37 |
ENSRNOT00000010845
|
Calb1
|
calbindin 1 |
chr15_+_15275541 | 29.21 |
ENSRNOT00000012153
|
Cadps
|
calcium dependent secretion activator |
chrX_+_107370431 | 29.19 |
ENSRNOT00000044372
|
Tceal1
|
transcription elongation factor A like 1 |
chr15_+_3936786 | 29.13 |
ENSRNOT00000066163
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr12_-_24710019 | 29.06 |
ENSRNOT00000049601
|
Stx1a
|
syntaxin 1A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
38.8 | 116.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
26.1 | 78.2 | GO:0001966 | thigmotaxis(GO:0001966) |
25.8 | 128.9 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
25.7 | 77.0 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
24.7 | 74.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
23.5 | 70.5 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
21.2 | 21.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
20.8 | 83.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
20.6 | 61.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
18.6 | 111.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
18.2 | 18.2 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
17.5 | 52.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
17.3 | 51.9 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
17.3 | 17.3 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
17.2 | 51.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
17.0 | 85.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
17.0 | 68.0 | GO:0021586 | pons maturation(GO:0021586) |
16.9 | 50.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
15.8 | 47.5 | GO:1904700 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
15.4 | 46.3 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
15.4 | 108.0 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
15.1 | 45.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
15.1 | 60.5 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
14.9 | 89.5 | GO:0010045 | response to nickel cation(GO:0010045) |
14.9 | 44.6 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
14.8 | 29.6 | GO:0072197 | ureter morphogenesis(GO:0072197) |
14.5 | 86.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
14.4 | 43.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
14.2 | 42.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
14.1 | 84.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
14.1 | 42.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
13.6 | 40.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
13.4 | 40.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
13.3 | 39.9 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
13.3 | 66.3 | GO:0030421 | defecation(GO:0030421) |
12.9 | 38.8 | GO:0060082 | eye blink reflex(GO:0060082) |
12.9 | 64.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
12.8 | 38.5 | GO:0035607 | ventricular zone neuroblast division(GO:0021847) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
12.7 | 38.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
12.2 | 36.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
12.2 | 36.5 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
12.0 | 48.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
12.0 | 24.0 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
12.0 | 12.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
11.8 | 11.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
11.6 | 34.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
11.5 | 34.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
11.2 | 56.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
11.2 | 44.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
11.1 | 33.4 | GO:2000769 | regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) |
11.1 | 33.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
11.1 | 55.4 | GO:0022009 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
10.9 | 97.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
10.9 | 43.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
10.8 | 32.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
10.8 | 32.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
10.8 | 129.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
10.7 | 42.8 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
10.6 | 53.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
10.5 | 31.6 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
10.3 | 41.3 | GO:0060022 | hard palate development(GO:0060022) |
10.2 | 50.9 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
10.2 | 20.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
10.1 | 60.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
9.9 | 59.5 | GO:0097338 | response to clozapine(GO:0097338) |
9.8 | 78.5 | GO:0046959 | habituation(GO:0046959) |
9.6 | 57.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
9.6 | 19.2 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
9.6 | 76.6 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
9.5 | 28.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
9.5 | 56.9 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
9.4 | 28.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
9.4 | 18.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
9.3 | 18.7 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
9.2 | 110.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
9.2 | 73.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
9.1 | 27.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
9.1 | 63.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
9.1 | 72.5 | GO:0051938 | L-glutamate import(GO:0051938) |
9.0 | 81.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
8.8 | 26.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
8.7 | 26.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
8.6 | 51.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
8.6 | 248.2 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
8.5 | 16.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
8.4 | 142.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
8.3 | 24.8 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
8.2 | 57.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
8.2 | 32.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
8.2 | 24.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
8.2 | 49.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
8.1 | 32.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
7.9 | 55.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
7.9 | 15.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
7.9 | 47.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
7.8 | 38.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
7.8 | 23.3 | GO:0035799 | ureter maturation(GO:0035799) |
7.7 | 23.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
7.7 | 23.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
7.6 | 7.6 | GO:0008355 | olfactory learning(GO:0008355) |
7.5 | 22.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
7.5 | 15.1 | GO:0098926 | postsynaptic signal transduction(GO:0098926) |
7.5 | 7.5 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
7.4 | 7.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
7.4 | 29.7 | GO:0034436 | glycoprotein transport(GO:0034436) |
7.4 | 22.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
7.3 | 51.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
7.2 | 21.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
7.1 | 35.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
7.0 | 14.0 | GO:0015827 | tryptophan transport(GO:0015827) |
7.0 | 34.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
6.9 | 20.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
6.8 | 88.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
6.7 | 6.7 | GO:1903937 | response to acrylamide(GO:1903937) |
6.7 | 26.8 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
6.7 | 26.7 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
6.6 | 13.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
6.6 | 6.6 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
6.6 | 6.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
6.6 | 19.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
6.6 | 26.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
6.5 | 32.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
6.5 | 13.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
6.5 | 19.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
6.4 | 38.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
6.4 | 19.1 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
6.3 | 19.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
6.3 | 19.0 | GO:0072218 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
6.3 | 19.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
6.3 | 6.3 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
6.3 | 18.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
6.3 | 6.3 | GO:0046958 | nonassociative learning(GO:0046958) |
6.2 | 24.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
6.2 | 24.9 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
6.2 | 31.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
6.2 | 6.2 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
6.2 | 18.5 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
6.2 | 240.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
6.1 | 30.6 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
6.1 | 6.1 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
6.1 | 18.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
6.1 | 18.2 | GO:0061744 | motor behavior(GO:0061744) |
6.1 | 18.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
6.1 | 36.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
5.9 | 17.8 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
5.9 | 29.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
5.9 | 23.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
5.9 | 100.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
5.9 | 41.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
5.8 | 11.7 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
5.8 | 5.8 | GO:0071504 | cellular response to heparin(GO:0071504) |
5.8 | 40.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
5.8 | 11.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
5.8 | 11.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
5.7 | 51.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
5.6 | 33.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
5.6 | 39.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
5.6 | 22.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
5.6 | 22.3 | GO:1900175 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
5.6 | 11.1 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
5.5 | 16.6 | GO:0061743 | motor learning(GO:0061743) |
5.5 | 33.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
5.5 | 22.0 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
5.5 | 43.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
5.5 | 11.0 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
5.5 | 5.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
5.4 | 5.4 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
5.4 | 26.9 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
5.4 | 16.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
5.3 | 79.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
5.3 | 10.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
5.3 | 53.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
5.3 | 26.5 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
5.3 | 21.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
5.3 | 15.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
5.2 | 20.9 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
5.2 | 15.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
5.2 | 15.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
5.2 | 31.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
5.2 | 20.6 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
5.1 | 41.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
5.1 | 30.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
5.1 | 15.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
5.1 | 35.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
5.1 | 10.2 | GO:0090427 | activation of meiosis(GO:0090427) |
5.1 | 56.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
5.1 | 15.3 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
5.1 | 5.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
5.1 | 10.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
5.1 | 30.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
5.1 | 15.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
5.0 | 25.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
5.0 | 70.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
5.0 | 14.9 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
5.0 | 34.7 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
4.9 | 29.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
4.9 | 9.8 | GO:0007412 | axon target recognition(GO:0007412) |
4.9 | 9.8 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
4.9 | 4.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
4.9 | 9.8 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
4.9 | 87.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
4.8 | 14.5 | GO:0035106 | operant conditioning(GO:0035106) |
4.8 | 9.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
4.8 | 14.4 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
4.8 | 177.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
4.8 | 14.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.8 | 23.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
4.7 | 137.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
4.7 | 4.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
4.7 | 14.1 | GO:1904373 | response to kainic acid(GO:1904373) |
4.7 | 32.9 | GO:0035934 | corticosterone secretion(GO:0035934) |
4.7 | 23.5 | GO:0051231 | spindle elongation(GO:0051231) |
4.7 | 41.9 | GO:0042711 | maternal behavior(GO:0042711) |
4.6 | 46.5 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
4.6 | 9.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
4.6 | 18.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
4.6 | 27.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
4.6 | 64.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
4.6 | 36.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
4.6 | 18.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.6 | 18.2 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
4.5 | 18.2 | GO:0036394 | amylase secretion(GO:0036394) |
4.5 | 27.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
4.5 | 9.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
4.5 | 22.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
4.5 | 4.5 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
4.5 | 45.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
4.5 | 13.5 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
4.5 | 53.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
4.4 | 48.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
4.4 | 26.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
4.4 | 4.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
4.4 | 8.8 | GO:0051255 | spindle midzone assembly(GO:0051255) |
4.4 | 13.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
4.4 | 39.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
4.4 | 17.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
4.3 | 4.3 | GO:0046099 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) guanosine-containing compound catabolic process(GO:1901069) |
4.3 | 13.0 | GO:0021997 | neural plate axis specification(GO:0021997) |
4.3 | 30.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
4.3 | 12.9 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
4.3 | 21.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
4.3 | 8.6 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
4.3 | 25.8 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
4.3 | 21.5 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
4.3 | 47.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
4.3 | 17.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
4.3 | 17.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
4.3 | 8.5 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
4.2 | 8.5 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
4.2 | 84.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
4.2 | 46.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
4.2 | 12.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
4.2 | 125.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
4.2 | 16.7 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
4.1 | 136.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
4.1 | 12.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
4.1 | 45.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.1 | 16.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
4.1 | 156.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
4.1 | 28.8 | GO:0035989 | tendon development(GO:0035989) |
4.1 | 4.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
4.1 | 8.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
4.1 | 24.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
4.1 | 24.5 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
4.1 | 56.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
4.0 | 40.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
4.0 | 12.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
4.0 | 322.0 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
4.0 | 48.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
4.0 | 19.9 | GO:0032264 | IMP salvage(GO:0032264) |
4.0 | 11.9 | GO:0032053 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
3.9 | 51.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
3.9 | 3.9 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
3.9 | 11.8 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
3.9 | 223.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.9 | 11.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
3.9 | 7.8 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
3.9 | 15.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
3.9 | 11.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
3.8 | 30.8 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
3.8 | 53.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
3.8 | 11.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
3.8 | 3.8 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
3.8 | 53.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
3.8 | 15.2 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
3.8 | 7.6 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
3.8 | 19.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
3.8 | 11.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
3.8 | 11.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
3.8 | 11.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.8 | 11.3 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
3.7 | 11.2 | GO:0071298 | cellular response to L-ascorbic acid(GO:0071298) |
3.7 | 11.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
3.7 | 18.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
3.7 | 14.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
3.7 | 14.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
3.7 | 7.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
3.7 | 11.1 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
3.7 | 14.8 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
3.7 | 3.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
3.7 | 22.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
3.7 | 29.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
3.6 | 25.5 | GO:0015871 | choline transport(GO:0015871) |
3.6 | 3.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.6 | 21.8 | GO:0046836 | glycolipid transport(GO:0046836) |
3.6 | 43.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
3.6 | 32.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
3.6 | 71.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
3.6 | 7.2 | GO:0003383 | apical constriction(GO:0003383) |
3.6 | 10.7 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
3.6 | 10.7 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
3.6 | 3.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
3.6 | 10.7 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
3.6 | 10.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.6 | 17.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.5 | 7.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
3.5 | 10.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
3.5 | 38.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
3.5 | 10.5 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
3.5 | 21.0 | GO:0030913 | paranodal junction assembly(GO:0030913) |
3.5 | 21.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
3.5 | 20.9 | GO:0015791 | polyol transport(GO:0015791) |
3.5 | 20.8 | GO:0006863 | purine nucleobase transport(GO:0006863) nucleobase transport(GO:0015851) |
3.5 | 6.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
3.4 | 65.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
3.4 | 10.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
3.4 | 13.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
3.4 | 23.6 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.4 | 13.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
3.4 | 13.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.4 | 90.7 | GO:0019835 | cytolysis(GO:0019835) |
3.3 | 10.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
3.3 | 10.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.3 | 13.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.3 | 16.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
3.3 | 9.9 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
3.3 | 9.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
3.3 | 16.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
3.3 | 9.9 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
3.3 | 49.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
3.3 | 3.3 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
3.2 | 3.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
3.2 | 13.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
3.2 | 19.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
3.2 | 29.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
3.2 | 16.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
3.2 | 9.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
3.2 | 3.2 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
3.2 | 9.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.2 | 9.5 | GO:0099612 | protein localization to axon(GO:0099612) |
3.2 | 47.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
3.1 | 106.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
3.1 | 9.4 | GO:0051697 | protein delipidation(GO:0051697) |
3.1 | 6.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
3.1 | 6.2 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
3.1 | 9.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
3.1 | 12.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
3.1 | 6.2 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
3.1 | 9.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
3.1 | 21.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
3.1 | 15.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.1 | 9.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.1 | 6.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
3.1 | 18.4 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
3.1 | 3.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
3.1 | 30.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
3.0 | 15.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.0 | 18.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
3.0 | 6.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
3.0 | 9.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
3.0 | 3.0 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
3.0 | 18.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
3.0 | 17.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
3.0 | 11.9 | GO:0031179 | peptide modification(GO:0031179) |
3.0 | 50.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.0 | 3.0 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
2.9 | 26.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
2.9 | 2.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.9 | 5.8 | GO:1904976 | cellular response to bleomycin(GO:1904976) |
2.9 | 5.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
2.9 | 8.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.9 | 14.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.9 | 14.4 | GO:0042756 | drinking behavior(GO:0042756) |
2.9 | 5.8 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
2.9 | 11.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
2.8 | 14.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
2.8 | 8.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
2.8 | 14.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
2.8 | 16.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
2.8 | 2.8 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
2.8 | 8.4 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
2.8 | 11.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.8 | 11.2 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
2.8 | 58.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
2.8 | 8.3 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
2.8 | 44.3 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
2.8 | 11.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.8 | 11.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.8 | 5.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
2.8 | 5.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.8 | 11.0 | GO:0044211 | CTP salvage(GO:0044211) |
2.7 | 5.5 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
2.7 | 11.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.7 | 21.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.7 | 16.4 | GO:0021759 | globus pallidus development(GO:0021759) |
2.7 | 5.5 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
2.7 | 19.1 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
2.7 | 8.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
2.7 | 8.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.7 | 2.7 | GO:1901258 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
2.7 | 5.4 | GO:0097037 | heme export(GO:0097037) |
2.7 | 10.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.7 | 5.4 | GO:0033058 | directional locomotion(GO:0033058) |
2.7 | 2.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
2.7 | 8.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.6 | 47.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
2.6 | 5.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.6 | 92.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
2.6 | 31.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
2.6 | 10.5 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
2.6 | 2.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
2.6 | 13.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
2.6 | 23.4 | GO:0060074 | synapse maturation(GO:0060074) |
2.6 | 18.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
2.6 | 2.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.6 | 36.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
2.6 | 7.8 | GO:1990523 | bone regeneration(GO:1990523) |
2.6 | 10.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
2.6 | 12.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.6 | 5.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
2.6 | 2.6 | GO:0051030 | snRNA transport(GO:0051030) |
2.6 | 12.8 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.6 | 5.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.5 | 2.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.5 | 15.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.5 | 2.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.5 | 2.5 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
2.5 | 7.6 | GO:0018343 | protein farnesylation(GO:0018343) |
2.5 | 15.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.5 | 27.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
2.5 | 7.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
2.5 | 7.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.5 | 15.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.5 | 5.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.5 | 19.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
2.5 | 29.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
2.5 | 7.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
2.5 | 2.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.5 | 17.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.4 | 2.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.4 | 2.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
2.4 | 14.6 | GO:0015074 | DNA integration(GO:0015074) |
2.4 | 17.1 | GO:1990403 | embryonic brain development(GO:1990403) |
2.4 | 12.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
2.4 | 12.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.4 | 2.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
2.4 | 21.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
2.4 | 7.2 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
2.4 | 31.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
2.4 | 19.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
2.4 | 48.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
2.4 | 9.6 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.4 | 9.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
2.4 | 48.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
2.4 | 26.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.4 | 9.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
2.4 | 11.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
2.4 | 4.7 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
2.4 | 9.4 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
2.4 | 4.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
2.4 | 11.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
2.3 | 30.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.3 | 9.4 | GO:0051958 | methotrexate transport(GO:0051958) |
2.3 | 9.3 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
2.3 | 11.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
2.3 | 20.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
2.3 | 27.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
2.3 | 4.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
2.3 | 55.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
2.3 | 16.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.3 | 16.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
2.3 | 6.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
2.3 | 6.9 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
2.3 | 2.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
2.3 | 6.9 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.3 | 2.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
2.3 | 9.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
2.3 | 4.6 | GO:0071029 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
2.3 | 11.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
2.3 | 22.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.3 | 15.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
2.2 | 11.2 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
2.2 | 24.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.2 | 9.0 | GO:0060023 | soft palate development(GO:0060023) |
2.2 | 33.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
2.2 | 22.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
2.2 | 15.4 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
2.2 | 6.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
2.2 | 4.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
2.2 | 4.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.2 | 2.2 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
2.2 | 10.9 | GO:0033227 | dsRNA transport(GO:0033227) |
2.2 | 2.2 | GO:0099630 | postsynaptic neurotransmitter receptor cycle(GO:0099630) |
2.2 | 4.3 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
2.1 | 15.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
2.1 | 10.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
2.1 | 2.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
2.1 | 4.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
2.1 | 2.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
2.1 | 16.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
2.1 | 20.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
2.1 | 23.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
2.1 | 6.3 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
2.1 | 8.3 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
2.1 | 4.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.1 | 6.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
2.1 | 107.3 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
2.1 | 6.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
2.0 | 49.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
2.0 | 6.1 | GO:0043474 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
2.0 | 14.2 | GO:0003360 | brainstem development(GO:0003360) |
2.0 | 12.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.0 | 10.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
2.0 | 6.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
2.0 | 20.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
2.0 | 14.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
2.0 | 10.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
2.0 | 16.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
2.0 | 15.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.0 | 13.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
2.0 | 29.7 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
2.0 | 11.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
2.0 | 2.0 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
2.0 | 7.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.0 | 5.9 | GO:0048749 | compound eye development(GO:0048749) |
2.0 | 11.7 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.9 | 13.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.9 | 11.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
1.9 | 55.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
1.9 | 11.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.9 | 9.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.9 | 3.8 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
1.9 | 11.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.9 | 1.9 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) |
1.9 | 9.5 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
1.9 | 13.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.9 | 5.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.9 | 5.6 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
1.9 | 5.6 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
1.9 | 3.7 | GO:0098597 | observational learning(GO:0098597) |
1.8 | 9.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.8 | 11.1 | GO:0001554 | luteolysis(GO:0001554) |
1.8 | 9.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.8 | 14.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.8 | 3.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.8 | 1.8 | GO:0036334 | epidermal stem cell homeostasis(GO:0036334) |
1.8 | 9.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.8 | 5.5 | GO:0007144 | female meiosis I(GO:0007144) |
1.8 | 14.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
1.8 | 113.2 | GO:0007612 | learning(GO:0007612) |
1.8 | 5.4 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
1.8 | 9.0 | GO:0080009 | mRNA methylation(GO:0080009) |
1.8 | 5.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.8 | 10.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
1.8 | 14.3 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
1.8 | 7.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.8 | 1.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.8 | 32.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.8 | 10.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.8 | 14.2 | GO:1901660 | calcium ion export(GO:1901660) |
1.8 | 40.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
1.8 | 58.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.8 | 39.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
1.8 | 15.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.8 | 8.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.8 | 7.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.7 | 17.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
1.7 | 8.7 | GO:0015884 | folic acid transport(GO:0015884) |
1.7 | 5.2 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
1.7 | 19.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.7 | 1.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.7 | 1.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.7 | 5.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
1.7 | 3.4 | GO:0006116 | NADH oxidation(GO:0006116) |
1.7 | 12.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
1.7 | 6.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.7 | 6.8 | GO:0048254 | snoRNA localization(GO:0048254) |
1.7 | 40.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
1.7 | 147.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.7 | 23.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.7 | 8.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.7 | 1.7 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
1.7 | 40.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
1.7 | 8.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.7 | 3.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.7 | 3.3 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
1.6 | 16.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.6 | 3.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.6 | 1.6 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
1.6 | 11.4 | GO:0014002 | astrocyte development(GO:0014002) |
1.6 | 8.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.6 | 4.8 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
1.6 | 3.2 | GO:1904612 | response to 2,3,7,8-tetrachlorodibenzodioxine(GO:1904612) |
1.6 | 6.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.6 | 4.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.6 | 9.6 | GO:0072176 | nephric duct development(GO:0072176) |
1.6 | 11.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.6 | 1.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.5 | 18.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.5 | 12.3 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.5 | 7.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.5 | 9.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.5 | 9.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.5 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
1.5 | 7.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.5 | 18.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.5 | 4.5 | GO:0019086 | late viral transcription(GO:0019086) |
1.5 | 3.0 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
1.5 | 4.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.5 | 7.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.5 | 5.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.5 | 1.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.5 | 96.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
1.5 | 14.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.5 | 10.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.5 | 5.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.5 | 13.2 | GO:0006465 | signal peptide processing(GO:0006465) |
1.5 | 8.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.5 | 4.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.4 | 37.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
1.4 | 1.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.4 | 4.3 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle checkpoint(GO:0031577) negative regulation of mitotic sister chromatid segregation(GO:0033048) spindle assembly checkpoint(GO:0071173) mitotic spindle checkpoint(GO:0071174) |
1.4 | 11.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.4 | 4.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.4 | 8.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.4 | 14.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
1.4 | 7.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.4 | 8.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.4 | 8.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.4 | 2.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.4 | 53.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
1.4 | 4.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.4 | 4.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.4 | 8.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
1.4 | 5.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.4 | 143.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
1.4 | 73.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
1.4 | 1.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.4 | 30.6 | GO:0097503 | sialylation(GO:0097503) |
1.4 | 1.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.4 | 1.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
1.4 | 5.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.4 | 1.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.4 | 4.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
1.4 | 4.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.4 | 1.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.4 | 2.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.4 | 8.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.4 | 1.4 | GO:1904907 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
1.4 | 21.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.3 | 2.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.3 | 6.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.3 | 4.0 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.3 | 4.0 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.3 | 4.0 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
1.3 | 14.5 | GO:0048278 | vesicle docking(GO:0048278) |
1.3 | 7.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.3 | 1.3 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
1.3 | 5.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.3 | 15.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
1.3 | 3.9 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
1.3 | 1.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.3 | 3.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.3 | 10.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.3 | 6.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.3 | 9.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
1.3 | 7.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.3 | 3.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.3 | 8.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
1.3 | 16.4 | GO:0036065 | fucosylation(GO:0036065) |
1.3 | 1.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.2 | 6.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.2 | 1.2 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) |
1.2 | 11.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.2 | 11.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.2 | 6.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.2 | 2.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.2 | 1.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
1.2 | 7.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.2 | 12.1 | GO:0016266 | O-glycan processing(GO:0016266) |
1.2 | 1.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
1.2 | 2.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.2 | 2.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.2 | 7.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.2 | 4.8 | GO:0016322 | neuron remodeling(GO:0016322) |
1.2 | 8.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.2 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.2 | 3.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.2 | 3.5 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
1.2 | 5.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
1.2 | 1.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.2 | 1.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.2 | 5.8 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.1 | 8.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.1 | 1.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.1 | 4.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.1 | 3.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
1.1 | 3.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.1 | 2.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.1 | 4.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
1.1 | 10.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
1.1 | 12.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.1 | 2.2 | GO:0042891 | antibiotic transport(GO:0042891) |
1.1 | 7.8 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
1.1 | 5.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.1 | 20.9 | GO:0007416 | synapse assembly(GO:0007416) |
1.1 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.1 | 15.4 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
1.1 | 2.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.1 | 2.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.1 | 2.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) bile acid signaling pathway(GO:0038183) |
1.1 | 2.2 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
1.1 | 2.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.1 | 4.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.1 | 4.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
1.1 | 8.5 | GO:0051653 | spindle localization(GO:0051653) |
1.1 | 5.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 2.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.0 | 10.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 4.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.0 | 10.4 | GO:0016926 | protein desumoylation(GO:0016926) |
1.0 | 6.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
1.0 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.0 | 40.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.0 | 23.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.0 | 5.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
1.0 | 8.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.0 | 1.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.0 | 1.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
1.0 | 2.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
1.0 | 3.0 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
1.0 | 3.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
1.0 | 1.0 | GO:0006272 | leading strand elongation(GO:0006272) |
1.0 | 4.9 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
1.0 | 12.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.0 | 5.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.0 | 52.1 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
1.0 | 2.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.0 | 3.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.0 | 6.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.0 | 2.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.0 | 3.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 7.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.0 | 1.0 | GO:0043132 | NAD transport(GO:0043132) |
1.0 | 14.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
1.0 | 1.0 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
1.0 | 1.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.0 | 6.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.0 | 42.8 | GO:0030010 | establishment of cell polarity(GO:0030010) |
1.0 | 10.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.9 | 0.9 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.9 | 3.8 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.9 | 1.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.9 | 5.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 13.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.9 | 8.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.9 | 41.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.9 | 2.8 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.9 | 12.0 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.9 | 9.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.9 | 13.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.9 | 2.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.9 | 2.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.9 | 23.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.9 | 1.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.9 | 7.2 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.9 | 0.9 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
0.9 | 5.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 47.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.9 | 9.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.9 | 6.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.9 | 4.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.9 | 6.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.9 | 5.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.9 | 3.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.9 | 11.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.9 | 1.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.9 | 1.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.9 | 3.4 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.8 | 62.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.8 | 0.8 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.8 | 5.9 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.8 | 3.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 1.7 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.8 | 2.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.8 | 2.5 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.8 | 14.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.8 | 2.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.8 | 1.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 3.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.8 | 3.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.8 | 1.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 41.3 | GO:0010970 | establishment of localization by movement along microtubule(GO:0010970) |
0.8 | 8.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.8 | 11.9 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.8 | 1.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.8 | 6.3 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.8 | 6.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.8 | 7.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.8 | 3.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.8 | 9.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.8 | 7.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.8 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.8 | 6.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 3.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.8 | 10.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.8 | 4.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.7 | 0.7 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.7 | 0.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 6.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.7 | 63.2 | GO:0099536 | synaptic signaling(GO:0099536) |
0.7 | 7.3 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.7 | 0.7 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.7 | 0.7 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.7 | 2.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.7 | 0.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.7 | 4.3 | GO:0033622 | integrin activation(GO:0033622) |
0.7 | 4.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.7 | 0.7 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.7 | 1.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 4.9 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.7 | 12.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.7 | 6.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.7 | 2.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.7 | 4.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.7 | 2.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 1.4 | GO:0097484 | dendrite extension(GO:0097484) |
0.7 | 2.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.7 | 3.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 3.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 5.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.7 | 2.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 9.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 1.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.6 | 0.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 1.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 6.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.6 | 3.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.6 | 5.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 1.9 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.6 | 7.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 1.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.6 | 0.6 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.6 | 1.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.6 | 6.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.6 | 1.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.6 | 5.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 7.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.6 | 7.0 | GO:0042044 | fluid transport(GO:0042044) |
0.6 | 50.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.6 | 1.2 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.6 | 31.3 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.6 | 2.9 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.6 | 2.9 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 2.3 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 0.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 10.2 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.6 | 0.6 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.6 | 1.7 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.5 | 0.5 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.5 | 3.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.5 | 1.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.5 | 1.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 2.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.5 | 1.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 1.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.5 | 1.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.5 | 3.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 3.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.5 | 2.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 1.0 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.5 | 3.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 5.6 | GO:0090382 | phagosome maturation(GO:0090382) |
0.5 | 1.0 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.5 | 1.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.5 | 1.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 1.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.5 | 1.5 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.5 | 3.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 6.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.5 | 3.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.5 | 0.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.5 | 32.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.5 | 0.9 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
0.5 | 2.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 1.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 4.0 | GO:0007051 | spindle organization(GO:0007051) |
0.4 | 0.4 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.4 | 2.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 2.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 8.4 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.4 | 3.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 6.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.4 | 1.7 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 3.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 12.5 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.4 | 1.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.4 | 2.9 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.4 | 1.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.2 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.4 | 0.8 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.4 | 3.6 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.4 | 0.4 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.4 | 23.1 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.4 | 2.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 1.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.4 | 1.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 2.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 3.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.4 | 1.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 2.6 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.4 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.4 | 13.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 4.6 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.3 | 1.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.3 | 2.0 | GO:0015866 | ADP transport(GO:0015866) |
0.3 | 2.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 1.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 2.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 2.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.3 | 2.3 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.3 | 85.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.3 | 2.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.3 | 3.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 6.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 0.6 | GO:0010037 | response to carbon dioxide(GO:0010037) |
0.3 | 2.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 0.9 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.3 | 0.9 | GO:0032218 | riboflavin transport(GO:0032218) |
0.3 | 0.8 | GO:0032288 | myelin assembly(GO:0032288) |
0.3 | 1.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.3 | 1.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.8 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 1.8 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 2.4 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 0.7 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 2.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 1.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.5 | GO:0052042 | killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.2 | 1.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 3.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 2.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 3.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 1.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.2 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.2 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.2 | 1.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.8 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.6 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) response to gold nanoparticle(GO:1990268) |
0.2 | 0.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 2.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 1.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 2.5 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.2 | 0.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 2.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 1.5 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.2 | 0.3 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.3 | GO:0033505 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.2 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.3 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.1 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.2 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.1 | 0.8 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.9 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 1.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 2.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.1 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 20.0 | GO:0007017 | microtubule-based process(GO:0007017) |
0.1 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 1.8 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.2 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 1.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.5 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.0 | 77.9 | GO:0032173 | septin collar(GO:0032173) |
22.9 | 68.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
20.6 | 103.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
19.1 | 133.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
18.1 | 54.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
16.3 | 261.3 | GO:0031045 | dense core granule(GO:0031045) |
15.6 | 46.9 | GO:0098830 | presynaptic endosome(GO:0098830) |
14.0 | 28.0 | GO:0044305 | calyx of Held(GO:0044305) |
12.8 | 38.4 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
12.3 | 73.6 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
10.8 | 32.3 | GO:0005592 | collagen type XI trimer(GO:0005592) |
10.1 | 111.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
10.0 | 40.1 | GO:0044308 | axonal spine(GO:0044308) |
10.0 | 29.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
9.8 | 107.7 | GO:0097470 | ribbon synapse(GO:0097470) |
9.5 | 114.5 | GO:0044327 | dendritic spine head(GO:0044327) |
9.5 | 75.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
9.3 | 27.8 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
9.1 | 401.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
9.1 | 27.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
9.0 | 99.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
9.0 | 9.0 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
8.8 | 26.3 | GO:0060187 | cell pole(GO:0060187) |
8.8 | 140.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
8.7 | 43.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
8.1 | 40.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
8.0 | 357.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
7.9 | 31.6 | GO:0033269 | internode region of axon(GO:0033269) |
7.6 | 37.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
7.5 | 7.5 | GO:0035101 | FACT complex(GO:0035101) |
7.5 | 74.6 | GO:0005883 | neurofilament(GO:0005883) |
7.4 | 74.1 | GO:0043083 | synaptic cleft(GO:0043083) |
7.3 | 159.9 | GO:0032590 | dendrite membrane(GO:0032590) |
7.3 | 203.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
7.1 | 106.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
6.9 | 187.5 | GO:0043194 | axon initial segment(GO:0043194) |
6.9 | 62.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
6.8 | 163.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
6.8 | 33.8 | GO:0072534 | perineuronal net(GO:0072534) |
6.6 | 19.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
6.4 | 109.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
6.4 | 121.1 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
6.3 | 6.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
6.2 | 18.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
6.2 | 18.5 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
6.1 | 92.1 | GO:0071565 | nBAF complex(GO:0071565) |
6.0 | 30.1 | GO:0071953 | elastic fiber(GO:0071953) |
5.8 | 11.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
5.8 | 23.1 | GO:0032280 | symmetric synapse(GO:0032280) |
5.5 | 38.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
5.3 | 438.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
5.3 | 5.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
5.1 | 30.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
5.1 | 20.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
4.9 | 19.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
4.9 | 4.9 | GO:0001740 | Barr body(GO:0001740) |
4.9 | 14.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
4.8 | 9.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
4.7 | 289.3 | GO:0043198 | dendritic shaft(GO:0043198) |
4.6 | 32.5 | GO:0097449 | astrocyte projection(GO:0097449) |
4.6 | 115.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
4.6 | 22.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
4.5 | 9.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
4.5 | 183.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
4.4 | 62.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.4 | 13.2 | GO:1990423 | RZZ complex(GO:1990423) |
4.3 | 17.2 | GO:0042585 | germinal vesicle(GO:0042585) |
4.3 | 12.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
4.1 | 12.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
4.1 | 8.2 | GO:0097444 | spine apparatus(GO:0097444) |
4.1 | 16.4 | GO:0097513 | myosin II filament(GO:0097513) |
4.1 | 4.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
4.0 | 40.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
4.0 | 28.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
4.0 | 27.9 | GO:0051286 | cell tip(GO:0051286) |
4.0 | 51.5 | GO:0031143 | pseudopodium(GO:0031143) |
3.9 | 15.6 | GO:0097427 | microtubule bundle(GO:0097427) |
3.8 | 11.5 | GO:0000811 | GINS complex(GO:0000811) |
3.8 | 11.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
3.8 | 11.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
3.8 | 7.5 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
3.7 | 7.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
3.7 | 18.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
3.7 | 29.2 | GO:0031209 | SCAR complex(GO:0031209) |
3.6 | 14.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
3.6 | 636.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
3.6 | 7.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
3.6 | 536.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
3.6 | 21.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
3.6 | 21.6 | GO:1990393 | 3M complex(GO:1990393) |
3.6 | 39.1 | GO:0001939 | female pronucleus(GO:0001939) |
3.5 | 21.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
3.5 | 10.6 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) DNA replication preinitiation complex(GO:0031261) pre-replicative complex(GO:0036387) |
3.5 | 10.5 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
3.4 | 31.0 | GO:0045180 | basal cortex(GO:0045180) |
3.4 | 10.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
3.4 | 10.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
3.4 | 26.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
3.3 | 13.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.1 | 34.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
3.1 | 21.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
3.1 | 18.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
3.1 | 64.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
3.1 | 30.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
3.1 | 289.9 | GO:0098793 | presynapse(GO:0098793) |
3.0 | 69.9 | GO:0051233 | spindle midzone(GO:0051233) |
3.0 | 9.1 | GO:1990879 | CST complex(GO:1990879) |
3.0 | 157.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
3.0 | 91.6 | GO:0044295 | axonal growth cone(GO:0044295) |
2.9 | 17.5 | GO:0005955 | calcineurin complex(GO:0005955) |
2.9 | 26.1 | GO:1990635 | proximal dendrite(GO:1990635) |
2.9 | 11.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.9 | 101.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
2.9 | 43.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.9 | 86.3 | GO:0097060 | synaptic membrane(GO:0097060) |
2.8 | 34.2 | GO:0071437 | invadopodium(GO:0071437) |
2.8 | 8.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.8 | 19.6 | GO:0042382 | paraspeckles(GO:0042382) |
2.7 | 5.5 | GO:0005940 | septin ring(GO:0005940) |
2.7 | 57.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
2.7 | 59.8 | GO:0097440 | apical dendrite(GO:0097440) |
2.7 | 19.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.7 | 18.6 | GO:0032437 | cuticular plate(GO:0032437) |
2.6 | 34.3 | GO:0000124 | SAGA complex(GO:0000124) |
2.6 | 5.2 | GO:0070695 | FHF complex(GO:0070695) |
2.6 | 13.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
2.6 | 7.7 | GO:0016939 | kinesin II complex(GO:0016939) |
2.5 | 10.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.5 | 17.4 | GO:0005683 | U7 snRNP(GO:0005683) |
2.5 | 24.6 | GO:0070652 | HAUS complex(GO:0070652) |
2.5 | 7.4 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
2.4 | 29.1 | GO:0031932 | TORC2 complex(GO:0031932) |
2.4 | 26.5 | GO:0032589 | neuron projection membrane(GO:0032589) |
2.4 | 7.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.4 | 85.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
2.4 | 23.6 | GO:0042555 | MCM complex(GO:0042555) |
2.3 | 176.4 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
2.3 | 67.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
2.2 | 13.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
2.2 | 240.2 | GO:0060076 | excitatory synapse(GO:0060076) |
2.2 | 6.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
2.2 | 6.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.1 | 77.0 | GO:0005871 | kinesin complex(GO:0005871) |
2.1 | 12.7 | GO:0016589 | NURF complex(GO:0016589) |
2.1 | 16.8 | GO:0005869 | dynactin complex(GO:0005869) |
2.1 | 25.0 | GO:0005796 | Golgi lumen(GO:0005796) |
2.1 | 39.4 | GO:0005922 | connexon complex(GO:0005922) |
2.0 | 24.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
2.0 | 15.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.9 | 7.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.9 | 5.7 | GO:0030478 | actin cap(GO:0030478) |
1.9 | 11.4 | GO:0034464 | BBSome(GO:0034464) |
1.9 | 5.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.9 | 5.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.8 | 9.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.8 | 33.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.8 | 49.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.8 | 1.8 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.8 | 23.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.8 | 7.2 | GO:0032021 | NELF complex(GO:0032021) |
1.8 | 9.0 | GO:0001772 | immunological synapse(GO:0001772) |
1.8 | 19.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.8 | 15.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.7 | 12.2 | GO:0000796 | condensin complex(GO:0000796) |
1.7 | 8.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.7 | 47.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.7 | 5.0 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.7 | 8.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.6 | 16.5 | GO:0034709 | methylosome(GO:0034709) |
1.6 | 4.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.6 | 19.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.6 | 4.9 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
1.6 | 17.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.6 | 4.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.6 | 14.2 | GO:0005688 | U6 snRNP(GO:0005688) |
1.6 | 9.4 | GO:0042641 | actomyosin(GO:0042641) |
1.6 | 4.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.5 | 7.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.5 | 6.2 | GO:0032584 | growth cone membrane(GO:0032584) |
1.5 | 4.6 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
1.5 | 9.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.5 | 1.5 | GO:0005642 | annulate lamellae(GO:0005642) |
1.5 | 3.0 | GO:0097542 | ciliary tip(GO:0097542) |
1.5 | 12.0 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 9.0 | GO:0036396 | MIS complex(GO:0036396) |
1.5 | 37.3 | GO:0031253 | cell projection membrane(GO:0031253) |
1.5 | 5.9 | GO:1990745 | EARP complex(GO:1990745) |
1.5 | 4.4 | GO:0043203 | axon hillock(GO:0043203) |
1.4 | 59.1 | GO:0031901 | early endosome membrane(GO:0031901) |
1.4 | 8.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.4 | 12.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.4 | 69.2 | GO:0031902 | late endosome membrane(GO:0031902) |
1.4 | 2.8 | GO:0031527 | filopodium membrane(GO:0031527) |
1.4 | 9.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.4 | 2.8 | GO:0000125 | PCAF complex(GO:0000125) |
1.4 | 15.3 | GO:0030904 | retromer complex(GO:0030904) |
1.4 | 25.1 | GO:0005605 | basal lamina(GO:0005605) |
1.4 | 81.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.4 | 97.2 | GO:0030426 | growth cone(GO:0030426) |
1.4 | 38.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.4 | 2.7 | GO:1990923 | PET complex(GO:1990923) |
1.3 | 21.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.3 | 12.0 | GO:0044298 | cell body membrane(GO:0044298) |
1.3 | 5.3 | GO:0071797 | LUBAC complex(GO:0071797) |
1.3 | 95.3 | GO:0005604 | basement membrane(GO:0005604) |
1.3 | 48.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.3 | 22.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.3 | 2.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.3 | 6.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.3 | 221.9 | GO:0045202 | synapse(GO:0045202) |
1.3 | 52.7 | GO:0016235 | aggresome(GO:0016235) |
1.3 | 225.4 | GO:0005874 | microtubule(GO:0005874) |
1.3 | 126.2 | GO:0030027 | lamellipodium(GO:0030027) |
1.3 | 21.3 | GO:0043679 | axon terminus(GO:0043679) |
1.2 | 7.4 | GO:0097433 | dense body(GO:0097433) |
1.2 | 6.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.2 | 2.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.2 | 8.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.2 | 19.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.2 | 8.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.2 | 95.3 | GO:0043204 | perikaryon(GO:0043204) |
1.2 | 27.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.2 | 5.8 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 9.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.1 | 75.9 | GO:0000786 | nucleosome(GO:0000786) |
1.1 | 8.8 | GO:0005921 | gap junction(GO:0005921) |
1.1 | 15.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.1 | 4.4 | GO:0032044 | DSIF complex(GO:0032044) |
1.1 | 51.3 | GO:0005581 | collagen trimer(GO:0005581) |
1.1 | 15.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.1 | 9.8 | GO:0070938 | contractile ring(GO:0070938) |
1.1 | 17.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.1 | 5.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.0 | 5.2 | GO:0035976 | AP1 complex(GO:0035976) |
1.0 | 14.5 | GO:0097546 | ciliary base(GO:0097546) |
1.0 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.0 | 70.0 | GO:0000776 | kinetochore(GO:0000776) |
1.0 | 9.8 | GO:0030008 | TRAPP complex(GO:0030008) |
1.0 | 9.8 | GO:0044420 | extracellular matrix component(GO:0044420) |
1.0 | 9.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 23.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.0 | 3.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.9 | 1.9 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.9 | 5.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 17.6 | GO:0005657 | replication fork(GO:0005657) |
0.9 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 2.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.9 | 3.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.9 | 2.7 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.9 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 7.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.9 | 3.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 8.9 | GO:0070187 | telosome(GO:0070187) |
0.9 | 3.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 11.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.9 | 7.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.9 | 40.0 | GO:0016592 | mediator complex(GO:0016592) |
0.9 | 2.6 | GO:0033503 | HULC complex(GO:0033503) |
0.9 | 5.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 8.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.9 | 3.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.8 | 45.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.8 | 2.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 5.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 3.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 32.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.8 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.8 | 0.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.8 | 18.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.8 | 3.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.8 | 5.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.8 | 8.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.8 | 10.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.8 | 3.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.8 | 3.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.8 | 51.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.8 | 13.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 6.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.8 | 18.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 1.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 1.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 11.9 | GO:0000145 | exocyst(GO:0000145) |
0.7 | 7.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.7 | 13.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.7 | 9.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.7 | 1.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.7 | 6.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.7 | 43.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.7 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.7 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.7 | 1.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 4.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 10.6 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 126.4 | GO:0043025 | neuronal cell body(GO:0043025) |
0.6 | 3.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 3.1 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 2.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 1.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 10.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.6 | 1.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 5.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 2.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 6.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.5 | 5.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 7.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 4.7 | GO:0032982 | myosin filament(GO:0032982) |
0.5 | 3.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 3.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 5.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.5 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 1.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 1.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.5 | 8.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 1.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 3.6 | GO:0044447 | axoneme part(GO:0044447) |
0.4 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 19.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 2.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 1.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.4 | 2.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 49.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.4 | 4.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 3.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 24.4 | GO:0005814 | centriole(GO:0005814) |
0.4 | 0.8 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.4 | 8.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 3.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.4 | 4.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 8.2 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 2.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 40.9 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.4 | 1.5 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 1.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.4 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 14.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.4 | 241.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.4 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 67.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 2.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 4.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 0.3 | GO:1990037 | Lewy body core(GO:1990037) |
0.3 | 2.7 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 1.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 0.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 8.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 3.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.7 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 2.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 4.8 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 64.8 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.2 | 7.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 15.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 699.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 1.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 60.4 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.2 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.0 | 2.8 | GO:0030141 | secretory granule(GO:0030141) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.9 | 115.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
26.2 | 131.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
24.5 | 147.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
23.5 | 23.5 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
20.1 | 120.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
17.8 | 53.4 | GO:0035939 | microsatellite binding(GO:0035939) |
17.4 | 121.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
17.2 | 68.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
15.5 | 46.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
15.5 | 61.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
15.4 | 108.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
15.1 | 60.5 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
14.9 | 59.5 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
14.2 | 56.9 | GO:0099510 | calcium ion binding involved in regulation of cytosolic calcium ion concentration(GO:0099510) |
13.0 | 64.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
12.3 | 73.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
12.2 | 97.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
12.1 | 36.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
11.8 | 164.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
11.7 | 35.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
11.7 | 35.0 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
11.6 | 58.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
11.1 | 77.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
11.0 | 33.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
11.0 | 32.9 | GO:0016015 | morphogen activity(GO:0016015) |
10.2 | 61.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
10.2 | 10.2 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
10.1 | 30.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
10.0 | 49.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
10.0 | 29.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
9.7 | 29.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
9.7 | 38.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
9.5 | 28.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
9.5 | 47.3 | GO:0070052 | collagen V binding(GO:0070052) |
9.4 | 18.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
9.3 | 74.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
9.1 | 27.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
9.0 | 35.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
9.0 | 44.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
8.9 | 44.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
8.9 | 17.8 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
8.8 | 26.4 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
8.5 | 110.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
8.5 | 34.0 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
8.5 | 25.4 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
8.0 | 32.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
8.0 | 24.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
8.0 | 31.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
7.8 | 39.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
7.7 | 15.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
7.7 | 30.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
7.5 | 22.6 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
7.5 | 30.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
7.5 | 67.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
7.4 | 14.9 | GO:0031762 | follicle-stimulating hormone receptor binding(GO:0031762) |
7.4 | 104.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
7.4 | 59.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
7.4 | 37.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
7.3 | 94.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
7.2 | 36.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
7.2 | 43.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
7.2 | 21.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
7.1 | 21.4 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
6.9 | 205.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
6.8 | 40.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
6.8 | 115.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
6.8 | 47.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
6.5 | 19.4 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
6.5 | 38.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
6.4 | 38.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
6.3 | 44.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.3 | 18.9 | GO:0005113 | patched binding(GO:0005113) |
6.3 | 18.8 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
6.3 | 162.7 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
6.2 | 18.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
6.2 | 24.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
6.1 | 6.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
6.0 | 54.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
5.8 | 23.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
5.7 | 57.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
5.6 | 337.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
5.6 | 28.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
5.6 | 16.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
5.6 | 77.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
5.5 | 72.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
5.5 | 22.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
5.4 | 21.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
5.4 | 43.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
5.4 | 16.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
5.4 | 128.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
5.3 | 16.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
5.3 | 26.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
5.3 | 26.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
5.3 | 21.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.3 | 26.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
5.3 | 36.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
5.3 | 10.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
5.2 | 36.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
5.2 | 20.9 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
5.2 | 46.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.2 | 52.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
5.1 | 30.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
5.0 | 55.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
5.0 | 25.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
5.0 | 14.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
4.9 | 14.8 | GO:0008481 | sphinganine kinase activity(GO:0008481) |
4.9 | 14.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
4.9 | 19.6 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
4.9 | 39.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
4.9 | 14.7 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
4.9 | 14.7 | GO:0004359 | glutaminase activity(GO:0004359) |
4.9 | 14.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
4.8 | 19.3 | GO:0019002 | GMP binding(GO:0019002) |
4.8 | 153.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
4.8 | 14.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
4.8 | 28.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
4.7 | 52.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
4.6 | 13.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
4.6 | 69.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
4.6 | 18.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
4.6 | 18.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
4.6 | 18.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
4.5 | 4.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
4.5 | 257.0 | GO:0019894 | kinesin binding(GO:0019894) |
4.5 | 72.0 | GO:0031005 | filamin binding(GO:0031005) |
4.4 | 4.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
4.4 | 61.3 | GO:0005522 | profilin binding(GO:0005522) |
4.3 | 51.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
4.3 | 42.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
4.2 | 12.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
4.2 | 50.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
4.2 | 20.9 | GO:0048495 | Roundabout binding(GO:0048495) |
4.2 | 25.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
4.1 | 16.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
4.1 | 49.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
4.1 | 20.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
4.1 | 36.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
4.0 | 16.1 | GO:0086077 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
4.0 | 28.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.9 | 47.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
3.9 | 54.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
3.9 | 11.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.9 | 62.1 | GO:0030955 | potassium ion binding(GO:0030955) |
3.9 | 498.3 | GO:0044325 | ion channel binding(GO:0044325) |
3.8 | 11.5 | GO:0043495 | protein anchor(GO:0043495) |
3.8 | 19.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.8 | 11.4 | GO:0022852 | glycine-gated chloride ion channel activity(GO:0022852) |
3.8 | 11.3 | GO:0005119 | smoothened binding(GO:0005119) |
3.7 | 18.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
3.7 | 11.1 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
3.7 | 40.5 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
3.7 | 21.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.6 | 3.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.6 | 10.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
3.6 | 53.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
3.5 | 17.7 | GO:0030911 | TPR domain binding(GO:0030911) |
3.5 | 21.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
3.5 | 21.1 | GO:0034452 | dynactin binding(GO:0034452) |
3.5 | 93.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
3.4 | 24.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
3.4 | 10.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
3.4 | 17.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
3.4 | 54.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
3.4 | 10.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
3.4 | 13.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
3.4 | 20.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
3.4 | 30.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
3.4 | 10.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.3 | 16.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
3.3 | 26.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
3.3 | 46.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
3.3 | 9.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
3.3 | 19.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
3.3 | 9.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.3 | 26.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
3.3 | 32.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
3.3 | 45.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
3.2 | 16.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
3.2 | 16.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.2 | 16.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
3.2 | 74.1 | GO:0031489 | myosin V binding(GO:0031489) |
3.2 | 86.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
3.2 | 19.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
3.1 | 18.9 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.1 | 9.4 | GO:0051425 | PTB domain binding(GO:0051425) |
3.1 | 93.6 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
3.1 | 12.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.1 | 9.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
3.1 | 40.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.1 | 9.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.1 | 52.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
3.0 | 9.1 | GO:0071886 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding(GO:0071886) |
3.0 | 6.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
3.0 | 30.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
3.0 | 18.3 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
3.0 | 6.0 | GO:0038132 | neuregulin binding(GO:0038132) |
3.0 | 9.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
3.0 | 6.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.0 | 6.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
3.0 | 3.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
3.0 | 5.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.0 | 11.9 | GO:0034711 | inhibin binding(GO:0034711) |
3.0 | 88.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
2.9 | 8.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.9 | 8.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
2.9 | 8.8 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
2.9 | 14.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
2.9 | 8.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
2.9 | 63.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
2.8 | 91.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.8 | 8.4 | GO:0004096 | catalase activity(GO:0004096) |
2.8 | 2.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
2.7 | 27.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.7 | 10.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
2.7 | 30.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.7 | 10.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.7 | 84.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.7 | 13.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.7 | 5.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.7 | 21.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.7 | 10.6 | GO:0036033 | mediator complex binding(GO:0036033) |
2.6 | 10.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.6 | 15.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.6 | 15.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.6 | 7.8 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
2.6 | 28.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.6 | 12.9 | GO:0001729 | ceramide kinase activity(GO:0001729) |
2.6 | 113.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
2.6 | 10.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.6 | 12.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.5 | 12.7 | GO:0070401 | NADP+ binding(GO:0070401) |
2.5 | 78.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
2.5 | 25.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
2.5 | 39.7 | GO:0015643 | toxic substance binding(GO:0015643) |
2.5 | 22.2 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
2.4 | 9.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
2.4 | 9.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.4 | 7.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
2.4 | 12.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.4 | 16.9 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.4 | 14.5 | GO:0030274 | LIM domain binding(GO:0030274) |
2.4 | 7.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
2.4 | 4.8 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
2.4 | 57.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
2.4 | 9.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
2.4 | 18.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
2.4 | 44.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
2.3 | 9.4 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
2.3 | 11.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
2.3 | 20.9 | GO:0051861 | glycolipid binding(GO:0051861) |
2.3 | 11.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.3 | 25.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.3 | 16.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
2.3 | 11.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.3 | 6.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.3 | 45.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
2.3 | 11.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.3 | 11.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.3 | 13.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
2.3 | 6.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.3 | 31.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
2.2 | 8.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
2.2 | 8.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
2.2 | 118.8 | GO:0005267 | potassium channel activity(GO:0005267) |
2.1 | 19.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
2.1 | 6.3 | GO:0042731 | PH domain binding(GO:0042731) |
2.1 | 10.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.1 | 2.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.1 | 8.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.0 | 6.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
2.0 | 24.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
2.0 | 87.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
2.0 | 21.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.0 | 6.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.0 | 13.9 | GO:0003896 | DNA primase activity(GO:0003896) |
2.0 | 5.9 | GO:0001083 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.9 | 9.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.9 | 436.1 | GO:0008017 | microtubule binding(GO:0008017) |
1.9 | 57.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.9 | 21.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
1.9 | 55.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.9 | 7.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
1.9 | 30.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.9 | 13.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.9 | 7.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.9 | 5.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.9 | 3.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.9 | 7.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.9 | 7.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.8 | 9.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.8 | 9.1 | GO:0000150 | recombinase activity(GO:0000150) |
1.8 | 9.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.8 | 18.1 | GO:0048156 | tau protein binding(GO:0048156) |
1.8 | 161.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.8 | 21.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.8 | 69.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.8 | 5.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.8 | 12.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.8 | 63.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.7 | 47.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.7 | 15.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
1.7 | 26.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
1.7 | 8.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.7 | 29.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.7 | 3.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.7 | 22.0 | GO:0051400 | BH domain binding(GO:0051400) |
1.7 | 13.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.7 | 1.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
1.7 | 11.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.7 | 8.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.7 | 3.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.6 | 21.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
1.6 | 9.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.6 | 7.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.6 | 70.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.6 | 9.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.6 | 6.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.6 | 6.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.6 | 10.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.6 | 3.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.6 | 87.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.6 | 3.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.5 | 12.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
1.5 | 12.2 | GO:0031402 | sodium ion binding(GO:0031402) |
1.5 | 6.0 | GO:0035240 | dopamine binding(GO:0035240) |
1.5 | 3.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.5 | 6.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.5 | 3.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.5 | 4.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.5 | 28.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.5 | 5.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.4 | 10.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.4 | 5.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.4 | 14.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.4 | 18.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.4 | 4.2 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
1.4 | 8.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.4 | 8.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
1.4 | 9.7 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
1.4 | 4.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 2.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.4 | 4.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.4 | 4.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
1.4 | 9.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.4 | 283.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.4 | 1.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.3 | 4.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.3 | 4.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.3 | 4.0 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
1.3 | 29.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.3 | 34.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.3 | 30.5 | GO:0001968 | fibronectin binding(GO:0001968) |
1.3 | 2.6 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
1.3 | 11.8 | GO:0051378 | serotonin binding(GO:0051378) |
1.3 | 18.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.3 | 5.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.3 | 2.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.3 | 6.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.3 | 15.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.3 | 3.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.3 | 26.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.3 | 20.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.3 | 18.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.3 | 1.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.2 | 6.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.2 | 4.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.2 | 7.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.2 | 23.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.2 | 47.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.2 | 24.4 | GO:0030507 | spectrin binding(GO:0030507) |
1.2 | 24.3 | GO:0017022 | myosin binding(GO:0017022) |
1.2 | 54.4 | GO:0019003 | GDP binding(GO:0019003) |
1.2 | 19.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.2 | 14.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.2 | 614.9 | GO:0005509 | calcium ion binding(GO:0005509) |
1.2 | 11.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.2 | 3.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.2 | 52.6 | GO:0005516 | calmodulin binding(GO:0005516) |
1.2 | 5.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.2 | 9.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.2 | 3.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.1 | 4.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 11.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
1.1 | 2.3 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.1 | 27.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.1 | 2.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.1 | 3.4 | GO:0102390 | mycophenolic acid acyl-glucuronide esterase activity(GO:0102390) |
1.1 | 10.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.1 | 8.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 5.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.1 | 30.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.1 | 2.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.1 | 6.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.1 | 2.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.1 | 6.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.1 | 1.1 | GO:0035877 | death effector domain binding(GO:0035877) |
1.1 | 2.2 | GO:0005499 | vitamin D binding(GO:0005499) |
1.1 | 5.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 4.3 | GO:0043532 | angiostatin binding(GO:0043532) |
1.1 | 6.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.1 | 3.2 | GO:0052724 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.1 | 4.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.1 | 3.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.1 | 19.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.1 | 10.5 | GO:0033691 | sialic acid binding(GO:0033691) |
1.0 | 6.3 | GO:0048030 | disaccharide binding(GO:0048030) |
1.0 | 9.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.0 | 37.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.0 | 10.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.0 | 17.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.0 | 18.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.0 | 6.2 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
1.0 | 4.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 6.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.0 | 5.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.0 | 3.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.0 | 5.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 4.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.0 | 4.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.0 | 11.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.0 | 10.5 | GO:0030295 | protein kinase activator activity(GO:0030295) |
1.0 | 5.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.9 | 2.8 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.9 | 3.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.9 | 2.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 28.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.9 | 8.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.9 | 6.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.9 | 10.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.9 | 4.5 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.9 | 4.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.9 | 6.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 7.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.9 | 2.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.9 | 11.3 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.9 | 7.8 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.9 | 9.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.9 | 4.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.9 | 4.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.9 | 5.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 3.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 38.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.9 | 2.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 2.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 5.9 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.8 | 1.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.8 | 1.7 | GO:0042806 | fucose binding(GO:0042806) |
0.8 | 2.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 2.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.8 | 4.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 2.4 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.8 | 2.4 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 6.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 2.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 5.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.8 | 24.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.8 | 3.9 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.8 | 9.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.8 | 2.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 19.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.8 | 5.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.8 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.8 | 11.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.8 | 23.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.8 | 1.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 1.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.7 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 4.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.7 | 9.5 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 10.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.7 | 2.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.7 | 3.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.7 | 1.4 | GO:0030546 | receptor activator activity(GO:0030546) |
0.7 | 3.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.7 | 2.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.7 | 1.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.7 | 13.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.7 | 3.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 3.9 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.6 | 4.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 5.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.6 | 3.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 2.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 36.1 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 5.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.6 | 42.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.6 | 3.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.6 | 1.9 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 15.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.6 | 8.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.6 | 12.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.6 | 2.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.6 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 2.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.6 | 1.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 7.4 | GO:0097200 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 4.0 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 1.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.5 | 8.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 3.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 0.5 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.5 | 3.7 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.5 | 1.6 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 2.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 16.1 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 4.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 3.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 4.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.5 | 125.5 | GO:0005525 | GTP binding(GO:0005525) |
0.5 | 1.4 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.5 | 1.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.5 | 1.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 6.1 | GO:0008061 | chitin binding(GO:0008061) |
0.5 | 8.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 1.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.5 | 4.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 0.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 5.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 3.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.4 | 40.2 | GO:0008201 | heparin binding(GO:0008201) |
0.4 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 5.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 2.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 1.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 1.2 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.4 | 1.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 1.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 1.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.4 | 15.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.4 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 3.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 2.9 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.4 | 5.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.4 | 2.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.1 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 2.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 7.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 5.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 2.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 2.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 4.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 4.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.3 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 13.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 0.9 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
0.3 | 9.6 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.5 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.3 | 13.4 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 0.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.3 | 0.9 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.3 | 1.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 21.4 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.3 | 1.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 0.8 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.2 | 1.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 1.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.4 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 6.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 3.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.6 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 2.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.9 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 4.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 13.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 3.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 3.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 5.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 7.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 5.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0050497 | methylthiotransferase activity(GO:0035596) transferase activity, transferring alkylthio groups(GO:0050497) |
0.1 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0000832 | inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 10.9 | GO:0004672 | protein kinase activity(GO:0004672) |
0.0 | 2.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 161.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
7.1 | 21.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
5.6 | 84.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
5.4 | 16.2 | PID SHP2 PATHWAY | SHP2 signaling |
5.3 | 36.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
5.1 | 212.1 | PID REELIN PATHWAY | Reelin signaling pathway |
4.8 | 116.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
4.6 | 4.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
4.6 | 129.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
4.2 | 71.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
3.9 | 89.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.8 | 98.1 | PID RAS PATHWAY | Regulation of Ras family activation |
3.7 | 183.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
3.6 | 25.0 | PID IGF1 PATHWAY | IGF1 pathway |
3.5 | 111.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
3.4 | 119.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
3.4 | 109.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
3.1 | 37.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
3.0 | 60.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
3.0 | 6.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.9 | 20.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.8 | 22.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
2.6 | 125.8 | NABA COLLAGENS | Genes encoding collagen proteins |
2.5 | 66.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
2.5 | 373.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
2.4 | 9.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
2.3 | 73.9 | PID AURORA A PATHWAY | Aurora A signaling |
2.3 | 2.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.3 | 103.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
2.2 | 13.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
2.2 | 15.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.2 | 145.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
2.2 | 26.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.0 | 16.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.9 | 5.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.9 | 28.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.9 | 57.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.9 | 41.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.9 | 18.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.9 | 57.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.8 | 25.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.8 | 62.7 | PID ARF6 PATHWAY | Arf6 signaling events |
1.7 | 37.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.7 | 55.2 | PID RHOA PATHWAY | RhoA signaling pathway |
1.7 | 8.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.6 | 21.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.6 | 288.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.6 | 28.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.6 | 17.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.6 | 70.2 | PID PLK1 PATHWAY | PLK1 signaling events |
1.5 | 7.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.4 | 14.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.4 | 36.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.3 | 37.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.2 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.2 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 21.2 | PID CDC42 PATHWAY | CDC42 signaling events |
1.2 | 31.7 | PID ATR PATHWAY | ATR signaling pathway |
1.1 | 11.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.1 | 42.0 | PID ATM PATHWAY | ATM pathway |
1.1 | 18.2 | PID ENDOTHELIN PATHWAY | Endothelins |
1.1 | 12.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.0 | 4.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.0 | 3.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.9 | 5.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.9 | 23.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.9 | 37.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.8 | 14.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.8 | 14.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.8 | 5.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 9.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.8 | 14.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.7 | 5.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.7 | 8.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 12.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 26.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.7 | 4.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 6.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 5.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.6 | 11.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.6 | 4.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 25.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 18.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.5 | 148.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 4.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 15.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.5 | 1.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 5.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 4.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 4.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 2.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 3.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 4.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 0.8 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 5.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 4.6 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.8 | 342.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
13.8 | 123.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
12.2 | 182.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
11.1 | 199.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
10.6 | 158.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
8.7 | 218.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
8.7 | 8.7 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
8.6 | 445.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
8.0 | 136.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
7.6 | 113.6 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
7.1 | 77.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
6.9 | 6.9 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
6.8 | 101.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
6.6 | 99.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
6.3 | 81.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
6.2 | 18.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
6.0 | 71.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
5.9 | 23.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
5.9 | 29.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.8 | 128.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
5.8 | 93.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
5.8 | 5.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
5.7 | 183.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
5.6 | 219.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
5.6 | 67.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
5.5 | 138.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
5.1 | 25.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
5.1 | 91.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
5.0 | 155.8 | REACTOME KINESINS | Genes involved in Kinesins |
4.7 | 42.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
4.4 | 106.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
4.4 | 57.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
4.3 | 47.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
4.1 | 16.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
4.0 | 51.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
3.9 | 124.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.9 | 104.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
3.6 | 60.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
3.4 | 27.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.2 | 84.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
3.2 | 22.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
3.2 | 22.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
3.2 | 51.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
3.2 | 50.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
3.1 | 31.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
3.1 | 68.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
3.0 | 54.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.0 | 72.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
2.9 | 2.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
2.9 | 60.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.9 | 23.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.8 | 44.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.8 | 30.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.7 | 113.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
2.6 | 34.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
2.5 | 35.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
2.5 | 57.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.5 | 31.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.4 | 51.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
2.4 | 91.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
2.3 | 60.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
2.3 | 20.4 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
2.2 | 22.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.1 | 78.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
2.1 | 41.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
2.0 | 157.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.9 | 11.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.9 | 42.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.8 | 9.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.8 | 12.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.8 | 32.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.8 | 35.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.7 | 14.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.7 | 12.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.7 | 22.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.7 | 27.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.6 | 9.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.6 | 16.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.6 | 70.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.6 | 66.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.6 | 10.9 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.5 | 45.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.5 | 16.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.5 | 41.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.5 | 8.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
1.4 | 21.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.4 | 31.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.4 | 31.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.3 | 6.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.3 | 21.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.3 | 5.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.2 | 60.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.2 | 48.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
1.2 | 3.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
1.2 | 12.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.2 | 29.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.1 | 84.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.1 | 19.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.1 | 4.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.1 | 36.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.0 | 20.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.0 | 25.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
1.0 | 9.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.0 | 9.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 8.4 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.9 | 3.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 9.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.9 | 0.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.9 | 8.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.8 | 123.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.8 | 21.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.8 | 5.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.8 | 46.4 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.8 | 15.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.8 | 43.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.8 | 29.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.8 | 11.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.7 | 13.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.7 | 35.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.7 | 22.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.7 | 14.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.7 | 6.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 15.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 10.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 7.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 10.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 5.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 12.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 9.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 4.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 7.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 3.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.5 | 6.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.5 | 2.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 3.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.4 | 7.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 1.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 5.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 32.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 13.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.3 | 1.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 6.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 2.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 4.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 23.0 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.2 | 2.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 4.8 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.2 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |